Medipharm Labs Corp (LABS) — Strategic Asset Allocation Index
Medipharm Labs Corp (LABS) has a Strategic Asset Allocation Index of 49.1% as of December 2025. Strategic assets (PP&E of CA$17.60 Million plus long-term investments of CA$-) total CA$17.60 Million, measured against net assets of CA$35.81 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Medipharm Labs Corp (LABS) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Medipharm Labs Corp Strategic Asset Allocation Index (2018–2025)
This chart shows how Medipharm Labs Corp's Strategic Asset Allocation Index has evolved across 8 annual periods from 2018 to 2025. As of December 2025, the index stands at 49.1%, representing strategic assets of CA$17.60 Million against net assets of CA$35.81 Million CAD. For live market cap and overall valuation, see LABS market cap.
Annual Strategic Asset Allocation Index for Medipharm Labs Corp (2018–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Medipharm Labs Corp from 2018 to 2025, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See LABS book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 49.1% | CA$17.60 Million | CA$17.60 Million | CA$- | CA$35.81 Million | ▲ +4.8 pp |
| 2024 | 44.4% | CA$19.16 Million | CA$19.16 Million | CA$- | CA$43.18 Million | ▼ -3.3 pp |
| 2023 | 47.7% | CA$25.27 Million | CA$25.27 Million | CA$- | CA$53.01 Million | ▲ +15.3 pp |
| 2022 | 32.3% | CA$18.11 Million | CA$18.11 Million | CA$- | CA$56.01 Million | ▲ +1.2 pp |
| 2021 | 31.1% | CA$25.89 Million | CA$25.89 Million | CA$0.00 | CA$83.15 Million | ▼ -12.6 pp |
| 2020 | 43.8% | CA$34.34 Million | CA$34.14 Million | CA$191.00K | CA$78.41 Million | ▲ +11.5 pp |
| 2019 | 32.3% | CA$42.42 Million | CA$42.23 Million | CA$189.00K | CA$131.23 Million | ▼ -18.1 pp |
| 2018 | 50.5% | CA$14.05 Million | CA$13.97 Million | CA$81.00K | CA$27.84 Million | — |